Based on our data, 14.28% of invasive GH-producing pituitary tumors showed weak expression of SOX9 protein expression (Score 1+), while 85.71% of invasive tumors revealed a moderate level of SOX9 protein (Score 2+). Here, SOX9 is linked to pituitary tumor.